KORU Medical Systems, Inc.
KORU Medical Systems, Inc. (Nasdaq: KRMD) develops, manufactures and commercializes large-volume subcutaneous infusion systems for drug delivery, serving patients who self-administer therapy at home as well as healthcare professionals in infusion centers. Its FREEDOM System includes the FREEDOM60 and FreedomEdge… From the company’s description.
Over the twelve months to Jun 30, 2026, KORU Medical Systems, Inc. reported revenue of $45.11M, up 22.4% from a year earlier, and a net loss of $1.82M. Its operating margin was −3.7%, and operations generated $1.39M in cash. In fiscal 2025, it reported revenue of $41.13M, up 22.2% from fiscal 2024, and a net loss of $2.64M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What KORU Medical Systems, Inc. does
In the company’s own words
KORU Medical Systems, Inc. (Nasdaq: KRMD) develops, manufactures and commercializes large-volume subcutaneous infusion systems for drug delivery, serving patients who self-administer therapy at home as well as healthcare professionals in infusion centers. Its FREEDOM System includes the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing, used primarily to deliver immunoglobulin therapies for conditions including primary immunodeficiency and chronic inflammatory demyelinating polyneuropathy. The system is also cleared for selected other therapies, including certain antibiotics and a biologic for generalized myasthenia. KORU’s revenues come from domestic core sales in the United States and Canada, international core sales, and pharma services and clinical trials, including product sales and engineering services for biopharmaceutical companies developing drugs. The company sells through distributors, specialty pharmacies and home infusion providers, and provides training materials to clinicians and patients. KORU manufactures all of its pump products and some consumables in-house, with the remainder of its consumables supply contract-manufactured. It had 73 full-time employees as of December 31, 2025.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- MAHWAH, NJ
- Fiscal year end
- December
- CIK
- 704440
- SIC
- 3841
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns KORU Medical Systems, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · KORU Medical Systems, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do KORU Medical Systems, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of KORU Medical Systems, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in KORU Medical Systems, Inc.'s last four quarterly filings that the numbers alone won't show?”